Bhalchandra Joshi

Dynamic pharmaceutical sales and marketing leader with over 26+ years of extensive experience across Ortho, Acute, Anti-infectives, Nutraceuticals, Pain Management, Wound Care, Gastroenterology, Ophthalmology, CP, GP, Gynecology, Pediatrics, Dermatology and Antiretroviral therapies. Built a strong pharmaceutical marketing career across renowned organizations, including Alkem, Alembic, Hetero, and FDC. Proven expertise in strategic marketing, brand leadership, portfolio expansion, product launches, business development, and building high-performing teams.

Demonstrated success in driving revenue growth, managing multiple flagship brands, executing innovative digital and phygital campaigns, strengthening KOL engagement, and leading large-scale business operations. Currently serving as Associate Vice President – Marketing at Pulse Pharma, leading the organization's flagship divisions — Maximus and Nucleus — with responsibility for strategic growth of key brands including DEKSEL.

Associate Vice President – Marketing at Pulse Pharma (2025-08 – Present)

• Leading strategic marketing operations for Pulse Pharma's flagship divisions — Maximus and Nucleus.
• Managing diversified portfolios across Ortho, CP & GP therapies through the Maximus Division.
• Overseeing Gynecology, Pediatrics, and Dermatology portfolios through the Nucleus Division.
• Driving strategic growth, market expansion and brand leadership for DEKSEL- organization's most important flagship brand.
• Leading brand planning, lifecycle management, portfolio expansion, scientific engagement, and promotional excellence initiatives.
• Collaborating closely with sales leadership, KOLs, and cross-functional teams to accelerate business growth and market penetration.

Associate Vice President – Sales at Hetero Healthcare (2024-03 – 2025-07)

• Led all-India operations for a ₹230 Cr portfolio with a 700+ member sales force.
• Managed strategic initiatives across Orthopedics, Nutraceuticals, Pain Management, Wound Healing, Antibiotics, Antivirals, and Anti-allergic therapies.
• Coordinated a series of webinars with Top Pedia KOL for the flagship Anti-viral brand (Fluvir)
• Strengthened Ortho KOL engagement through CME programs & therapy specific Ad-board.
• Successfully spearheaded the launch of the Ortho division (Ornova) & Dental Task force product finalisation
• Drove operational efficiencies, profitability, and market penetration through data-driven sales strategies.

Marketing Head (General Manager – Marketing) – Bergen at Alkem Laboratories (2012-09 – 2024-03)

Promoted as General Manager in July 2018. Promoted as Deputy General Manager in April 2016. Promoted as Senior Marketing Manager in July 2015. Joined as Marketing Manager in September 2012.

• Managed marketing responsibilities across multiple business divisions—Bergen United, Bergen Nova, and Bergen Crista.
• Led marketing for the Bergen cluster's key brands—Gemcal, Uprise D3, Ondem, Zocef, and Enzoflam
• Played a pivotal role in conceptualizing and launching the Bergen Nova and Bergen Crista divisions.
• Spearheaded Marketing for Bergen Crista post-divisionalization. - Managed a portfolio exceeding ₹270 Cr across Anti-infective, Pain Management, Wound Care, Hyperuricemia, and Neuropathy segments.
• Drove business growth and market leadership for flagship brands including ZOCEF & ENZOFLAM.
• Recipient of multiple APPLAUD Marketing Excellence Awards for Best Brand Launch, Brand Revitalization, and Digital Strategy.
• Conducted various KOL engagement initiatives – AAOS (American Association of Orthopedic Surgeons Conclave), Cadaver workshops & Zonal CMEs, National and Regional conferences.
• Led capability-building and training initiatives for field teams, from Medical Representatives to Senior Managers.

Group Product Manager – Megacare Division at Alembic Pharmaceuticals (2010-08 – 2012-09)

• Led marketing strategies for flagship brands including Azithral, Cepime-O, and Alzcort.
• Multiple KOL engagement initiatives with Derma & ENT specialties.
• Pioneered the first "Pedia Expert Opinion" webcast featuring 18 pediatric super-specialists with more than 1,400 online participants.
• Organized workshops, symposia, and CME activities for dermatologists, pediatricians, and ENT specialists.
• Achieved 120% target accomplishment with 38% growth for the Cepime-O group during FY 2011–12.
• Recognized with the Star Award (Singapore) for outstanding performance.

Group Product Manager | Genx & ARV Division at Hetero Healthcare (2006-06 – 2010-08)

• Single-handedly managed all marketing functions for the Anti-retroviral division since inception.
• Successfully launched TRUSTIVA, which became the No.1 product in the division.
• Led innovative launches including Virataz-R, the world's first thermostable Atazanavir + Ritonavir formulation.

Product Manager at FDC Limited (2004-04 – 2006-06)

• Managed flagship brands including Zathrin, Salmodil, Punarjal, and Flunarin.
• Developed brand plans, promotional campaigns, and sales growth strategies.

Product Executive at Ferring Pharmaceuticals (2003-01 – 2004-04)

• Managed gastroenterology portfolio including Pentasa and Remestyp.
• Developed Indian market strategies aligned with Sweden headquarters' guidelines.

Product Executive at LEKAR Healthcare (Division of JB Chemicals) (2001-11 – 2003-12)

• Managed generic product portfolios and contributed to strategic sales forecasting and business expansion initiatives.

Professional Service Representative at Croslands – Ranbaxy (1999-09 – 2001-11)

• Promoted dermatology, gynecology, and orthopedic product ranges in South Mumbai covering major Hospitals such as Hinduja, Lilavati, Guru Nanak, Holy Family, etc.

Bachelor of Pharmacy in Pharmacy – Nagpur University (1999)